Familial Amyloidosis Caused by Lysozyme

Protein Misfolding Diseases: Current and Emerging Principles and Therapies

Volumn , Issue , 2010, Pages 867-885

  Dumoulin, Mireille ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Clinical manifestations associated with human lysozyme amyloidoses and therapeutic approaches; Familial amyloidosis caused by lysozyme; Lysozyme amyloid fibril formation mechanism

Indexed keywords

EID: 84886193271     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470572702.ch39     Document Type: Chapter

References (39)

1. Reitamo, S., Klockars, M., Adinolfi, M., Osserman, E.F. (1978). Human lysozyme (origin and distribution in health and disease). Ric Clini Lab, 8, 211-231.
2. Jolles, P., Jolles, J. (1984). What's new in lysozyme research? Always a model system, today as yesterday. Mol Cell Biochem, 63, 165-189.
3. Pepys, M.B., Hawkins, P.N., Booth, D.R., Vigushin, D.M., Tennent, G.A., Soutar, A.K., Totty, N., Nguyen, O., Blake, C.C., Terry, C.J., et al. (1993). Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature, 362, 553-557.
4. Rocken, C., Becker, K., Fandrich, M., Schroeckh, V., Stix, B., Rath, T., Kahne, T., Dierkes, J., Roessner, A., Albert, F.W. (2006). ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene. Hum Mutat, 27, 119-120.
5. Valleix, S., Drunat, S., Philit, J.B., Adoue, D., Piette, J.C., Droz, D., MacGregor, B., Canet, D., Delpech, M., Grateau, G. (2002). Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int, 61, 907-912.
6. Yazaki, M., Farrell, S.A., Benson, M.D. (2003). A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int, 63, 1652-1657.
7. Gillmore, J.D., Booth, D.R., Madhoo, S., Pepys, M.B., Hawkins, P.N. (1999). Hereditary renal amyloidosis associated with variant lysozyme in a large English family. Nephrol Dial Transplant, 14, 2639-2644.
8. Booth, D.R., Pepys, M.B., Hawkins, P.N. (2000). A novel variant of human lysozyme (T70N) is common in the normal population. Hum Mutat, 16, 180.
9. Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Dobson, C.M., Radford, S.E., Blake, C.C., Pepys, M.B. (1997). Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature, 385, 787-793.
10. Esposito, G., Garcia, J., Mangione, P., Giorgetti, S., Corazza, A., Viglino, P., Chiti, F., Andreola, A., Dumy, P., Booth, D., et al. (2003). Structural and folding dynamics properties of T70N variant of human lysozyme. J Biol Chem, 278, 25910-25918.
11. Funahashi, J., Takano, K., Ogasahara, K., Yamagata, Y., Yutani, K. (1996). The structure, stability, and folding process of amyloidogenic mutant human lysozyme. J Biochem (Tokyo), 120, 1216-1223.
12. Johnson, R.J., Christodoulou, J., Dumoulin, M., Caddy, G.L., Alcocer, M.J., Murtagh, G.J., Kumita, J.R., Larsson, G., Robinson, C.V., Archer, D.B., et al. (2005). Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme. J Mol Biol, 352, 823-836.
13. Kumita, J.R., Johnson, R.J., Alcocer, M.J., Dumoulin, M., Holmqvist, F., McCammon, M.G., Robinson, C.V., Archer, D.B., Dobson, C.M. (2006). Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris. FEBS J, 273, 711-720.
14. Harrison, R.F., Hawkins, P.N., Roche, W.R., MacMahon, R.F., Hubscher, S.G., Buckels, J.A. (1996). 'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis. Gut, 38, 151-152.
15. Loss, M., Ng, W.S., Karim, R.Z., Strasser, S.I., Koorey, D.J., Gallagher, P.J., Verran, D.J., McCaughan, G.W. (2006). Hereditary lysozyme amyloidosis: spontaneous hepatic rupture (15 years apart) in mother and daughter. Role of emergency liver transplantation. Liver Transpl, 12, 1152-1155.
16. Granel, B., Serratrice, J., Valleix, S., Grateau, G., Droz, D., Lafon, J., Sault, M.C., Chaudier, B., Disdier, P., Laugier, R., et al. (2002). A family with gastrointestinal amyloidosis associated with variant lysozyme. Gastroenterology, 123, 1346-1349.
17. Pepys, M. B. (2001). Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos Trans R Soc Lond B, 356, 203-210.
18. Selkoe, D.J. (2003). Folding proteins in fatal ways. Nature, 426, 900-904.
19. Jimenez, J.L., Tennent, G., Pepys, M., Saibil, H.R. (2001). Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy. J Mol Biol, 311, 241-247.
20. Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B., Blake, C.C.F. (1997). Common core structure of amyloid fibrils by synchrotron x-ray diffraction. J Mol Biol, 273, 729-739.
21. Serpell, L.C., Sunde, M., Benson, M.D., Tennent, G.A., Pepys, M.B. Fraser, P.E. (2000). The protofilament substructure of amyloid fibrils. J Mol Biol, 300, 1033-1039.
22. Canet, D., Sunde, M., Last, A.M., Miranker, A., Spencer, A., Robinson, C.V., Dobson, C.M. (1999). Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. Biochemistry, 38, 6419-6427.
23. Hooke, S.D., Radford, S.E., Dobson, C.M. (1994). The refolding of human lysozyme: a comparison with the structurally homologous hen lysozyme. Biochemistry, 33, 5867-5876.
24. Takano, K., Funahashi, J., Yutani, K. (2001). The stability and folding process of amyloidogenic mutant human lysozymes. Eur J Biochem, 268, 155-159.
25. Wain, R., Smith, L.J., Dobson, C.M. (2005). Oxidative refolding of amyloidogenic variants of human lysozyme. J Mol Biol, 351, 662-671.
26. Dumoulin, M., Bellotti, V., Dobson, C.M. (2005). In The Beta Pleated Sheet Conformation and Diseases, Vol. II. (Sipe, J.D., (Ed.), VCH Verlag, Weinheim, Germany, pp. 635-656.
27. Dumoulin, M., Johnson, J.R.K., Bellotti, V., Dobson, C.M. (2007). In Protein Misfolding, Aggregation, and Conformational Diseases, Vol. 6 Uversky, V.N., Fink, A., Eds.), Springer, New York, pp. 285-308.
28. Dumoulin, M., Canet, D., Last, A.M., Pardon, E., Archer, D.B., Muyldermans, S., Wyns, L., Matagne, A., Robinson, C.V., Redfield, C., Dobson, C.M. (2005). Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J Mol Biol, 346, 773-788.
29. Dumoulin, M., Last, A.M., Desmyter, A., Decanniere, K., Canet, D., Larsson, G., Spencer, A., Archer, D.B., Sasse, J., Muyldermans, S., et al. (2003). A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature, 424, 783-788.
30. Morozova-Roche, L.A., Zurdo, J., Spencer, A., Noppe, W., Receveur, V., Archer, D.B., Joniau, M., Dobson, C.M. (2000). Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J Struct Biol, 130, 339-351.
31. Canet, D., Last, A.M., Tito, P., Sunde, M., Spencer, A., Archer, D.B., Redfield, C., Robinson, C.V., Dobson, C.M. (2002). Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat Struct Biol, 9, 308-315.
32. Harper, J.D., Lansbury, P.T., Jr. (1997). Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the timedependent solubility of amyloid proteins. Annu Rev Biochem, 66, 385-407.
33. Frare, E., Mossuto, M.F., Polverino de Laureto, P., Dumoulin, M., Dobson, C.M., Fontana, A. (2006). Identification of the core structure of lysozyme amyloid fibrils by proteolysis. J Mol Biol, 361, 551-561.
34. Vieira, M.N., Figueroa-Villar, J.D., Meirelles, M.N., Ferreira, S.T., De Felice, F.G. (2006). Small molecule inhibitors of lysozyme amyloid aggregation. Cell Biochem Biophys, 44, 549-553.
35. Kumita, J.R., Poon, S., Caddy, G.L., Hagan, C.L., Dumoulin, M., Yerbury, J.J., Stewart, E.M., Robinson, C.V., Wilson, M.R., Dobson, C.M. (2007). The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species. J Mol Biol, 369, 157-167.
36. Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L.G., Muyldermans, S., Wyns, L., Matagne, A. (2002). Single-domain antibody fragments with high conformational stability. Protein Sci, 11, 500-515.
37. Muyldermans, S. (2001). Single domain camel antibodies: current status. J Biotechnol, 74, 277-302.
38. Marquardt, A., Muyldermans, S., Przybylski, M. (2006). A synthetic camel antilysozyme peptide antibody (peptibody) with flexible loop structure identified by high-resolution affinity mass spectrometry. Chemistry, 12, 1915-1923.
39. Dumoulin, M., Kumita, J.R., Dobson, C.M. (2006). Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants. Acc Chem Res, 39, 603-610.